Published in Gene Therapy Weekly, December 7th, 2006
The milestone article, appearing in the International Journal of Oncology, reports on three clinical studies involving patients with various chemo-resistant tumor types who received Rexin-G in Phase I/II and expanded access protocols.
In the first study, progressive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly